Faster, clearer blood compatibility results now available NORCROSS, Ga., April 30, 2018 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next generation, fully automated Echo ® instrument, Echo Lumena TM , has received FDA clearance in the

NORCROSS, GA., July 26, 2017 – Immucor Inc., a global leader in transfusion and transplantation diagnostics, announces a partnership with CoLabs Laboratory Medicine Network. In a unified vision for a regional transfusion lab medicine model, this partnership is designed to drive innovation

NORCROSS, Ga., July 18, 2017  ̶  Immucor, Inc. (the “Company” or “Immucor”) today announced the expiration of an offer to eligible holders to exchange up to a maximum aggregate principal amount of $390 million of Immucor’s outstanding 11.125% Senior

NORCROSS, Ga., June 19, 2017 – Immucor, Inc. (the “ Company ” or “ Immucor ”) announced the commencement of an offer to eligible holders to exchange any and all of Immucor’s outstanding 11.125% Senior Notes due 2019 (the “ Old Notes ”) for a new

  NORCROSS, GA. and MANNHEIM, GERMANY (EFI BOOTH 10), May 31, 2017 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that ATC A.S. has been awarded a contract with the Turkish Ministry of Health for bone marrow registry HLA typing results,

NORCROSS, Ga., April 11, 2017 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Friday, April 21, 2017 at 11:00 a.m. ET to discuss its fiscal 2017 third quarter results.

NORCROSS, Ga, February 17, 2017 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced the launch of Pak Lx™, a qualitative Luminex®-based immunoassay that brings high-definition to platelet antibody testing.

New – Sample to Sequencing in less than 24 hours! NORCROSS, GA., February 14, 2017 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced the launch of the new MIA FORA® NGS FLEX HLA Typing Assay that provides comprehensive coverage of up to

Fastest throughput for immunohematology now powered with clearer results for brilliant performance and simplified blood testing verification NORCROSS, Ga. and ORLANDO, Fla. (AABB BOOTH 823), October 24, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics,

  Now recognized as a tool to identify SCT negative units in addition to extended antigen typings all in one test Reduces the time and expense of selecting units for patients requiring frequent transfusions, such as those with sickle cell disease Improves the decision-making process of which

NORCROSS, Ga., October 17, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Friday, October 21, 2016 at 11:00 a.m. ET to discuss its fiscal 2017 first quarter results.

Unique Organ Rejection Test is Available through Immucor’s Clinical Laboratory, Immucor DX™ NORCROSS, Ga., May 2, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced today the launch of its kidney Solid Organ Response Test, kSORT: a

Immucor achieves milestone to help healthcare providers receive reimbursement for molecular immunohematology assay NORCROSS, Ga., April 04, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc. , a global leader in transfusion and transplantation diagnostics, announced that Medicare Administrative Contractors

Enhanced Molecular Module Automates IVD Results for the First and Only Red Blood Cell Genotyping Test Approved by the FDA and Eligible for Reimbursement NORCROSS, Ga., March 21, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced FDA clearance

Transaction culminates successful collaboration to bring MIA FORA™ NGS offering for high resolution HLA typing to market NORCROSS, Ga., March 4, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced it has acquired Mountain View, CA-based

Approval enables European HLA laboratories and those beyond Europe requiring CE Mark to adopt differentiated next generation sequencing (NGS) solution for HLA typing NORCROSS, Ga., February 3, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, in

Collaboration brings unique next generation sequencing solution to the HLA typing market NORCROSS, Ga., December 22, 2015 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, in collaboration with Sirona Genomics, today announced the launch of MIA FORA NGS, a high

<em><li>LCD covers test for Medicare patients who can benefit from better-matched blood</li>
<li>Critical step in helping healthcare providers obtain reimbursement for claims</li></em>

Jeffrey R. Binder Appointed President and CEO of Immucor Norcross, Georgia - June 29, 2015- Immucor, Inc., a global leader in transfusion and transplantation diagnostics and a portfolio company of global private investment firm TPG, today announced the appointment of Jeffrey R.